» Articles » PMID: 32038995

Publication Landscape Analysis on Gliomas: How Much Has Been Done in the Past 25 Years?

Overview
Journal Front Oncol
Specialty Oncology
Date 2020 Feb 11
PMID 32038995
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The body of glioma-related literature has grown significantly over the past 25 years. Despite this growth in the amount of published research, gliomas remain one of the most intransigent cancers. The purpose of this study was to analyze the landscape of glioma-related research over the past 25 years using machine learning and text analysis. In April 2019, we downloaded glioma-related publications indexed in PubMed between 1994 and 2018. We used Python to extract the title, publication date, MeSH terms, and abstract from the metadata of each publication for bibliometric assessment. Latent Dirichlet allocation (LDA) was applied to the abstracts to identify publications' research topics with greater specificity. We identified and analyzed a total of 52,625 publications in our study. We found that research on prognosis and the treatment of glioblastoma increased the most in terms of volume and rate of publications over the past 25 years. However, publications regarding clinical trials accounted for <5% of all publications considered in this study. The current research landscape covers clinical, pre-clinical, biological, and technical aspects of glioblastoma; at present, researchers appear to be less concerned with glioblastoma's psychological effects or patients' end-of-life care. Publication of glioma-related research has expanded rapidly over the past 25 years. Common topics include the disease's molecular background, patients' survival, and treatment outcomes; more research needs to be done on the psychological aspects of glioblastoma and end-of-life care.

Citing Articles

Deep brain stimulation and Parkinson disease: a bibliometric and visual analysis (1993-2023).

Abdallat M, Abumurad S, Tarazi A, Ammar A, Zyoud M, AlMomani D Neurosurg Rev. 2025; 48(1):24.

PMID: 39762644 DOI: 10.1007/s10143-025-03178-w.


Global publication productivity and research trends on recurrent ovarian cancer: a bibliometric study.

Xu H, Wang L, Xu D Front Oncol. 2024; 14:1422213.

PMID: 39035742 PMC: 11257877. DOI: 10.3389/fonc.2024.1422213.


Machine Learning-based Analysis of Publications Funded by the National Institutes of Health's Initial COVID-19 Pandemic Response.

Chandrabhatla A, Narahari A, Horgan T, Patel P, Sturek J, Davis C Open Forum Infect Dis. 2024; 11(4):ofae156.

PMID: 38659624 PMC: 11041405. DOI: 10.1093/ofid/ofae156.


Adverse Effects of Non-Metallic Nanoparticles in the Central Nervous System.

Sikorska K, Sawicki K, Czajka M, Kapka-Skrzypczak L, Kruszewski M, Brzoska K Materials (Basel). 2023; 16(23).

PMID: 38068008 PMC: 10707257. DOI: 10.3390/ma16237264.


Technical Aspects of Motor and Language Mapping in Glioma Patients.

Al-Adli N, Young J, Sibih Y, Berger M Cancers (Basel). 2023; 15(7).

PMID: 37046834 PMC: 10093517. DOI: 10.3390/cancers15072173.


References
1.
Chen X, Xie H, Wang F, Liu Z, Xu J, Hao T . A bibliometric analysis of natural language processing in medical research. BMC Med Inform Decis Mak. 2018; 18(Suppl 1):14. PMC: 5872501. DOI: 10.1186/s12911-018-0594-x. View

2.
Friedman H, Prados M, Wen P, Mikkelsen T, Schiff D, Abrey L . Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009; 27(28):4733-40. DOI: 10.1200/JCO.2008.19.8721. View

3.
Atci I, Yilmaz H, Samanci M . The top 50 most-cited articles on low-grade glioma: a bibliometric analysis. Br J Neurosurg. 2019; 33(2):171-175. DOI: 10.1080/02688697.2018.1549314. View

4.
Nieder C, Pawinski A, Dalhaug A . Contribution of case reports to glioblastoma research: systematic review and analysis of pattern of citation. Br J Neurosurg. 2012; 26(6):809-12. DOI: 10.3109/02688697.2012.692842. View

5.
Stout N, Alfano C, Belter C, Nitkin R, Cernich A, Lohmann Siegel K . A Bibliometric Analysis of the Landscape of Cancer Rehabilitation Research (1992-2016). J Natl Cancer Inst. 2018; 110(8):815-824. PMC: 6279275. DOI: 10.1093/jnci/djy108. View